Evidence map›Paper›PMID 36915381›Full record

ArticleComputational and structural biotechnology journal2023

Rushikesh Singh Dasoondi, Tom L Blundell, Arun Prasad Pandurangan

Open access · goldFull text read
In one paragraph

Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rushikesh Singh DasoondiDepartment of Biochemistry, University of Cambridge, United Kingdom.
Tom L BlundellDepartment of Biochemistry, University of Cambridge, United Kingdom.
Arun Prasad PanduranganDepartment of Biochemistry, University of Cambridge, United Kingdom.
University of Cambridge · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Multi-drug resistant tuberculosis is categorised by the World Health Organisation (WHO) as a public health crisis.

Identifiers

PMID36915381
PMCPMC10006719
OpenAlexW4321460191

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.